Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma (clinicaltrials.gov) - Sep 17, 2026 - P1 | N=50 | Recruiting | Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Trial completion date: Jul 2027 ➔ Apr 2027 | Trial primary completion date: Jul 2026 ➔ Apr 2027
Trial completion date • Trial primary completion date • Melanoma • Oncology • Solid Tumor
|